/Companies

Healthtech Startups

18,748 companies tagged Healthtech, with their investors and founders.

Bobo Labs

0 investors

Body Details

0 investors

Bone Foam

0 investors

Bonne Sante Group

0 investors

Boston Health Economic Holdings

0 investors

Botany Scientifics

0 investors

bQuest

bQuest connects financial advisors with a vetted network of aging care, end-of-life, and after-loss specialists to help clients and families navigate care crises. The platform uses AI-powered guidance to support wealth management firms in serving aging populations.

0 investors

Bradford Health Holdings

0 investors

Bradford Health Holdings II

0 investors

Bradford Health Partners

0 investors

Brain Armor

0 investors

Brain Synergy Institute

0 investors

BrainXell

BrainXell is a company focused on advancing research and improving patient outcomes through scientific work and services. Its stated mission centers on neuroscience-related research, associated with Dr. Su-Chun Zhang.

0 investors

Branch Therapeutics

Branch Therapeutics develops first-in-class, orally available dual-kinase inhibitors designed to modulate WNT/β-catenin and PI3Kα signaling to target cancer stem cells and treatment resistance in solid tumors. The company pairs its therapies with a precision biomarker strategy aimed at safer, longer-lasting responses to cancer treatment.

0 investors

Branchpoint Technologies

0 investors

Breakthrough Behavior

0 investors

Breakthrough Products

0 investors

Breast Microseed

0 investors

Breathe Better Institute

Breathe Better is an ENT clinic offering minimally invasive, in-office sinus treatments such as Balloon Sinuplasty for adults with chronic sinus and allergy conditions. It serves patients in the Huntsville and North Alabama area.

0 investors

Brevitest Technologies

0 investors

Bridge Therapeutics

Bridge Therapeutics is a development-stage pharmaceutical company developing BT-219 (Bunalz), a buprenorphine/naloxone orally disintegrating tablet for Opioid Use Disorder, and BT-205, a buprenorphine/meloxicam sublingual combination for chronic pain in opioid-experienced patients. Both drug candidates are being pursued through the FDA 505(B)(2) approval pathway.

0 investors

Bridge TO Life

0 investors

BridgepointMD

0 investors

BRIGHT.MD INC.

0 investors

Other sectors & tags